Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implicationsJorge Berlanga‐Acosta, Luis Herrera-Martínez, Jorge Gavilondo‐Cowley et al.|International Wound Journal|2009Cited by 167
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired HealingJorge Berlanga‐Acosta, Luis Herrera-Martínez, Marianela García-Siverio et al.|BioMed Research International|2012Cited by 153
Impacto perjudicial del exceso agudo y crónico de glucosa en células involucradas en la cicatrización: fibroblastos, miofibroblastos y células precursoras vascularesJorge Berlanga‐Acosta, Luis Herrera-Martínez, Ernesto López‐Mola et al.|Unknown|2012Cited by 2
A narrative review on Epidermal Growth Factor (EGF) intralesional infiltrations for diabetic complex wounds: The rational of an innovative delivery routeJorge Berlanga‐Acosta, Gerardo Guillén, Jose Fernandez-Montequin et al.|Vascular Diseases and Therapeutics|2022Cited by 2
Detrimental impact of acute and chronic glucose burden in wound-healing cells: fibroblasts, myofibroblasts and vascular precursor cellsJorge Berlanga‐Acosta, Luis Herrera-Martínez, Ernesto López‐Mola et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2012Cited by 1